195 related articles for article (PubMed ID: 17852455)
1. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
2. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
[TBL] [Abstract][Full Text] [Related]
3. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
[TBL] [Abstract][Full Text] [Related]
5. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
[TBL] [Abstract][Full Text] [Related]
6. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
8. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
9. Antisense targeting of p-glycoprotein expression in tissue culture.
Nakamura K; Kubo A; Hnatowich DJ
J Nucl Med; 2005 Mar; 46(3):509-13. PubMed ID: 15750166
[TBL] [Abstract][Full Text] [Related]
10. [Reversal of multidrug resistance in lung adenocarcinoma-resistant cell line A549/R by mdr1 antisense oligodeoxynucleotides in vitro].
Chen L; Liu Y
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):219-21. PubMed ID: 11798761
[TBL] [Abstract][Full Text] [Related]
11. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
Li Y; Wang Y
Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
[TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
Quattrone A; Papucci L; Morganti M; Coronnello M; Mini E; Mazzei T; Colonna FP; Garbesi A; Capaccioli S
Oncol Res; 1994; 6(7):311-20. PubMed ID: 7865906
[TBL] [Abstract][Full Text] [Related]
14. In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide.
Bai J; Yokoyama K; Kinuya S; Shiba K; Matsushita R; Nomura M; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1523-9. PubMed ID: 15449049
[TBL] [Abstract][Full Text] [Related]
15. [Reversal of mdrl gene-dependent multidrug resistance in multidrug resistance human leukemia cell line K562/ADM using short hairpin RNA expression vectors].
Gan HZ; Zhang GZ; Lu ZX; Pu LS; Yang SJ; Gao S; Zheng DM
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):383-7. PubMed ID: 17939403
[TBL] [Abstract][Full Text] [Related]
16. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
Fu J; Chen Z; Cen J; Ruan C
Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
[TBL] [Abstract][Full Text] [Related]
17. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
20. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]